X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Castor Launches CRO Partnership Program to Increase Adoption of Decentralized Clinical Trials

    Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

    Cytiva and NecstGen form strategic collaboration to accelerate development of cell and gene therapies

    Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials

    Valneva and Pfizer Report Further Positive Phase 2 Data for Lyme Disease Vaccine Candidate

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    BioMed X Institute and Merck KGaA, Darmstadt, Germany, Extend Collaboration in Oncology

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma's VP3 Nasal Spray System

    New Combination Product for Symptoms of Seasonal Allergic Rhinitis Approved by US FDA with Aptar Pharma’s VP3 Nasal Spray System

    Cryoport and Cell Matters Enter into Strategic Partnership

    Cryoport and Cell Matters Enter into Strategic Partnership

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology

    Gilead Announces Results From Phase 3 Trial of Remdesivir in Patients With Moderate COVID-19

    Gilead Sciences Announces FDA Approval of Veklury for Treatment of Non-Hospitalized Patients at High Risk for COVID-19

    Novavax to Participate in University of Oxford Com-COV2 Study Comparing Mixed COVID-19 Vaccine Combinations

    Australia Therapeutic Goods Administration Grants Provisional Registration for Novavax COVID-19 Vaccine

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Europe

Chemspec Europe 2018 in Cologne closes with a record in visitor numbers

Content Team by Content Team
6th July 2018
in Europe, News

The 33rd edition of Chemspec Europe, International Exhibition for Fine and Speciality Chemicals, endedafter two successful show days with record visitor numbers. From

20 to 21 June 2018, a total of 4,202 trade visitors came to the exhibition grounds of the Koelnmesse in Cologne, Germany, where international experts of the fine and speciality chemicals industry met for Europe’s leading exhibition. These figures represent an increase of visitor numbers by nearly 9% compared to last year’s show in Munich.

The results of Chemspec Europe’s 33rd edition are very gratifying: With a total of 358 exhibitors and 6,724 attendees from all over the world, the specialised industry event was able to further increase its overall attendance figure (exhibitors, visitors, press and conference delegates) compared to the 2017 show in Munich.This year’s Chemspec Europe attracted a total of 4,202 trade visitors which represents a plus in visitors ofnearly9%.

“We are very pleased that we could further increase the Chemspec Europevisitor numbers. The sustainable growth of the exhibition reflects the overall positive industry outlook where a reliable network is absolutely crucial.For international industry experts, Chemspec Europe has become an absolute must-attend event in the trade fair calendar if you want to stay up-to-date with current trends, like bio-based chemicals, flexible manufacturing processes or strategic collaborations, and meet top decision-makersin the fine and speciality chemicals industry”, said Liljana Goszdziewski, Exhibition Director of Chemspec Europe, on behalf of the organisers, Mack Brooks Exhibitions.

At Chemspec Europe 2018, the 358 exhibitors from 27 countries showcased a wide variety of fine and speciality chemicals for a large range of applications on a net floor space of 6,075m2. The major European exhibitor countries were Germany, the UK, France, Belgium and Switzerland. Non-European exhibitors mainly came from China, India and the USA.

Visitors to Chemspec Europe 2018 came from a total of 66 countries; predominantly from Germany (39%), followed by the UK, the Netherlands,Switzerland, France, India, Italy, China, Belgium, Spainand the USA.
The preliminary results of the exhibition survey show that the majority of visitors came from the following industries: Pharma, agriculture, plastics and polymers, paints and coatings, research and development, cosmetics, toiletries and personal care, petrochemicals, contract and toll manufacturing, adhesives and sealants as well as water treatment. The majority of visitors were manufacturers, distributors, raw material suppliers or equipment suppliers and work in research and development or for consulting firms. The main responsibilities of the visitors within their companies were senior management,purchasing and procurement, research and development, and marketing.

Visitors were mainly interested in the following products and services: Chemical intermediates, general chemicals,industrial chemicals, pharmaceuticals, agrochemicals, APIs, polymers,custom synthesis, green chemicals and catalysts.

Broadconference programmevery well received
Visitors to this year’s Chemspec Europe had the opportunity toattend several conferences and workshops covering many different topics. In cooperation with renowned partner organisations, the conferences did not only offer insightsinto trends and prospects, but also encouraged exchange and networking with international industry colleagues.

The conference programme included the “Agrochemical Outlook Conference”, sponsored byAgrow Magazine,as well as the“Innovative Startups”conference,organised incooperation with BCNP Consultants,which included short presentations of young startups on the topic“New Paths to Fine and Specialty Chemicals”.In the Pharma Lecture Theatre,visitors could listen to lectures about trends and challenges in the pharma industry, including a presentation given by Dr MagidAbou-Gharbia, Moulder Center for Drug Discovery Research, andthe“Pharma Outsourcing Best Practices Panel”.Furthermore, the conference programme included the two day“RSC Symposium” of the Royal Society of Chemistry, the“Regulatory Services Conference”,organised byREACHReady,as well as the“Crop Protection & Fine Chemicals Forum”held by EFCG (The European Fine Chemicals Group).

High re-booking rate among exhibitors for Chemspec Europe 2019 in Basel
An initial evaluation of the exhibition survey revealed that exhibitors, visitors and conference delegates were highly satisfied with the show. A large majority of exhibitors already secured their stands for Chemspec Europe 2019whilst on-site. As a result, approximately 75% of the total net floor space is already booked and reserved for the upcoming exhibition.

Chemspec Europe 2019will take place from 26 to 27 June 2019 in hall 1.0 of Messe Basel, Switzerland. The Basel region is one of Europe’s major hubs for the fine and speciality chemicals industry and borders three of Europe’s strongest countries in this sector – Germany, France and Switzerland.

Previous Post

Bruker Launches New Sierra™ SPR-32 High-Performance Surface Plasmon Resonance System at SLAS Europe 2018

Next Post

Anima Biotech announces an exclusive collaboration with Lilly for the discovery and development of translation inhibitors of several protein targets

Related Posts

Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
News

Indian Scientists Claim To Design Vaccine For All Variants

9th February 2022
Drones for Delivery To Carry Pharmaceutical Weight Forward
News

Drones for Delivery To Carry Pharmaceutical Weight Forward

9th February 2022
America Facing Heart Health Issues Since The Pandemic Began
News

America Facing Heart Health Issues Since The Pandemic Began

8th February 2022
T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants
News

T2 Biosystems T2SARS-CoV-2 Panel Detects Omicron Subvariants

7th February 2022
OLUMIANT® (baricitinib) 2-mg Tablets gets FDA approval to treat adult patients with moderately to severely active Rheumatoid Arthritis
Manufacturing

Lilly announces $1 billion investment in new manufacturing facility in North Carolina

7th February 2022
Recipharm supports FDA approval of Perrigos AB-rated generic product
News

Recipharm acquires GenIbet to bolster Biologics offering

7th February 2022
Next Post

Anima Biotech announces an exclusive collaboration with Lilly for the discovery and development of translation inhibitors of several protein targets

Latest News

Envirotainer introduces the RAP for the future - part of the Releye series
Packaging & Logistic

Envirotainer introduces the RAP for the future – part of the Releye series

14th February 2022
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers
Packaging & Logistic

Opticooler receives technical approval by Japanese major airlines

14th February 2022
Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease
Press Statements

Aptar Pharma Launches HeroTracker Sense, Novel Connected Smart Device for Respiratory Disease

14th February 2022
Johnson & Johnson Prepares to Resume Phase 3 ENSEMBLE Trial of its Janssen COVID-19 Vaccine Candidate in the U.S.
News

Indian Scientists Claim To Design Vaccine For All Variants

9th February 2022
Drones for Delivery To Carry Pharmaceutical Weight Forward
News

Drones for Delivery To Carry Pharmaceutical Weight Forward

9th February 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In